Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01590862 · ClinicalTrials.gov registry record · NA
ON/OFF Stimulation and Reward Motivation in Patients With Deep Brain Stimulators
A NA study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 13
- Enrollment target
NCT01590862: Completed NA study, sponsored by Massachusetts General Hospital.
NCT01590862 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 13 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01590862, a NA study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 13 participants
- Enrollment target
Study Summary
We propose to study approach/avoidance behavior as measured by the Approach Avoidance task in 20 epilepsy patients undergoing implementation of depth electrodes for seizure monitoring in the Epilepsy Monitoring Unit at MGH. We will also study the effects of VC/VS electrical stimulation on approach-avoidance conflict in 20 adult patients who have undergone DBS implantation for severe MDD and/or OCD. There are 100-200 patients in the world with DBS electrodes in the VC/VS, and our research team cares for more than any other institution. Both participant groups will be assessed with respect to reward-aversion decision conflict using the task. The task will be performed with concurrent EEG recordings in DBS patients, and with continuous recording through our invasive neurophysiology rig in EMU subjects.
Interventions
- DEVICE Deep Brain Stimulator
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2021-01-23 |
| Est. Completion | 2026-03-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01590862
The ClinicalTrials.gov registry entry for NCT01590862 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Deep Brain Stimulator is the first listed.
NCT01590862 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01590862 about?
NCT01590862 is a clinical study titled "ON/OFF Stimulation and Reward Motivation in Patients With Deep Brain Stimulators". We propose to study approach/avoidance behavior as measured by the Approach Avoidance task in 20 epilepsy patients undergoing implementation of depth electrodes for seizure monitoring in the Epilepsy Monitoring Unit at MGH. We will also study the effects of VC/VS electrical stimulation on approach-a...
What is the current status of trial NCT01590862?
This trial is currently completed. It is a NA study. The enrollment target is 13 participants. The study started on 2021-01-23. Estimated completion is 2026-03-31.
What interventions are being tested in trial NCT01590862?
The interventions under investigation include: Deep Brain Stimulator (DEVICE).
Who is sponsoring clinical trial NCT01590862?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.